Last reviewed · How we verify
Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS (Venus)
The objective of this study is to assess the immunogenicity and safety of the DTaP-IPV combination vaccine compared with those of separate DTaP and IPV vaccines administered to healthy infants at 2, 4, and 6 months of age.
Details
| Lead sponsor | Boryung Pharmaceutical Co., Ltd |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 476 |
| Start date | Mon Feb 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat May 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Diphtheria
- Tetanus
- Pertussis
- Poliomyelitis
Interventions
- DTaP-IPV combination vaccine
- DTaP vaccine and IPV vaccine
Countries
Thailand, South Korea